CPC A61K 31/7052 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 31/194 (2013.01); A61K 31/7048 (2013.01); A61K 47/10 (2013.01); A61P 27/02 (2018.01); A61P 27/04 (2018.01)] | 27 Claims |
1. A method for treating dry eye disease comprising:
administering a pharmaceutical formulation comprising between about 1% and about 20% azelaic acid,
wherein the pharmaceutical formulation is administered to an external surface of the lower eyelid below lower lashes daily for at least 1 month, and wherein administering the pharmaceutical formulation reduces a symptom of dry eye disease.
|